
Sign up to save your podcasts
Or


In the October 29, 2024 issue of JACC, Dr. Valentin Fuster explores groundbreaking studies on heart failure treatments, including the impact of sacubitril-valsartan on hypotension, the benefits of intravenous iron for reducing hospitalizations, the prognostic value of platelet FCγRIIA in post-myocardial infarction patients, and innovative AI assessments of environmental factors influencing cardiovascular risk.
By American College of Cardiology4.2
162162 ratings
In the October 29, 2024 issue of JACC, Dr. Valentin Fuster explores groundbreaking studies on heart failure treatments, including the impact of sacubitril-valsartan on hypotension, the benefits of intravenous iron for reducing hospitalizations, the prognostic value of platelet FCγRIIA in post-myocardial infarction patients, and innovative AI assessments of environmental factors influencing cardiovascular risk.

135 Listeners

321 Listeners

498 Listeners

886 Listeners

19 Listeners

32 Listeners

3,360 Listeners

138 Listeners

1,142 Listeners

62 Listeners

40 Listeners

198 Listeners

91 Listeners

368 Listeners

428 Listeners